跳至主要内容
临床试验/NL-OMON42831
NL-OMON42831尚未招募不适用

St. Jude Medical HeartMate® PHP CE Mark Post Approval Study - PHP PAS

St. Jude Medical0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * At least 18 years of age.
  • * Patient presents with a non-emergent need for complex PCI and in the opinion of the investigator is a risk of hemodynamic compromise during PCI.
  • * Written, signed, and dated informed consent

排除标准

  • *Emergent PCI
  • *ST elevation myocardial infarction within 7 days of procedure
  • *Cardiac arrest within 7 days of procedure requiring CPR or defibrillation
  • *Hemodynamic support with the HeartMate PHP post-PCI is anticipated
  • *Cardiogenic shock (SBP <90 mmHg for >1 hour with either cool clammy skin OR oliguria OR altered sensorium OR cardiac index <2.2 L/min/m2)
  • *Mural thrombus in the left ventricle
  • *History of aortic valve replacement
  • *Documented presence of aortic stenosis (orifice area of 1.5cm2 or less)
  • *Moderate to severe aortic insufficiency (echocardiographic assessment of aortic insufficiency graded as 2 or higher)
  • *Severe peripheral vascular disease
  • *Abnormalities of the aorta that would preclude surgery, including aneurysms and significant tortuosity or calcifications
  • *Serum creatinine > 3.5mg/dL within 7 days of procedure
  • *Liver dysfunction with elevation of liver enzymes and bilirubin levels to * 3x ULN or INR (Internationalized Normalized Ratio) *2
  • *Uncorrectable abnormal coagulation parameters
  • *Active systemic infection requiring treatment with antibiotics
  • *Clinically relevant stroke or TIA within 3 months of procedure. Patients with suspected stroke or TIA within 3 months of procedure must have documented absence of neurological infarction
  • *Uncontrollable allergy or intolerance to heparin, aspirin, clopidogrel, ionic and nonionic contrast media, or any other potentially required anticoagulants or antiplatelet therapy drugs
  • *History of heparin induced thrombocytopenia
  • *Patient is pregnant or planning to become pregnant during the study period

研究者

相似试验